Covered recipient · General Payments record
RONALD PAUL CRAMER
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,716.28
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $488.41 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $256.47 | 15 |
| Ardelyx, Inc. | $50.20 | 3 |
| Janssen Biotech, Inc. | $42.76 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $36.10 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $31.28 | 1 |
| Merck Sharp & Dohme Corporation | $19.27 | 1 |
| VIVUS LLC | $18.62 | 1 |
| GENZYME CORPORATION | $17.45 | 1 |
| Ferring Pharmaceuticals Inc. | $16.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.51 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512662 | CMS |
| ABBVIE INC. | $19.49 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512664 | CMS |
| ABBVIE INC. | $7.29 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512666 | CMS |
| ABBVIE INC. | $13.42 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512668 | CMS |
| ABBVIE INC. | $5.64 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512670 | CMS |
| ABBVIE INC. | $6.75 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512672 | CMS |
| ABBVIE INC. | $15.36 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512674 | CMS |
| ABBVIE INC. | $22.66 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512676 | CMS |
| ABBVIE INC. | $16.16 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512678 | CMS |
| ABBVIE INC. | $20.52 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512680 | CMS |
| ABBVIE INC. | $18.98 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512682 | CMS |
| ABBVIE INC. | $22.00 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512684 | CMS |
| ABBVIE INC. | $20.55 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512686 | CMS |
| ABBVIE INC. | $26.37 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512688 | CMS |
| ABBVIE INC. | $19.77 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103512690 | CMS |
| Ardelyx, Inc. | $17.09 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146676676 | CMS |
| Ardelyx, Inc. | $15.88 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146676678 | CMS |
| Ardelyx, Inc. | $17.23 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146676680 | CMS |
| Ferring Pharmaceuticals Inc. | $16.26 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137471456 | CMS |
| GENZYME CORPORATION | $17.45 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139914679 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $31.28 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153726708 | CMS |
| Janssen Biotech, Inc. | $15.56 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078571770 | CMS |
| Janssen Biotech, Inc. | $27.20 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078571785 | CMS |
| Merck Sharp & Dohme LLC | $19.27 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141603682 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.10 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137520520 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.00 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137520524 | CMS |
| VIVUS LLC | $18.62 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415244 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.